$JCAP

Jefferson Capital, Inc. / DE

CIK:0002046042|SEC Filings

Combined and Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenues
Total portfolio income	$ 156,253	$ 138,877	$ 313,859	$ 277,571
Changes in recoveries	9,010	1,556	16,067	5,176
Total portfolio revenue	165,263	140,433	329,926	282,747
Credit card revenue	1,623	1,798	3,358	3,696
Servicing revenue	10,654	10,477	20,695	21,208
Total Revenues	177,540	152,708	353,979	307,651
Provision for credit losses	757	560	1,380	1,101
Operating Expenses
Salaries and benefits	21,880	6,254	44,255	20,276
Servicing expenses	64,822	43,546	130,400	86,339
Depreciation and amortization	844	1,250	1,716	2,854
Professional fees	3,053	9,444	5,334	11,611
Other selling, general and administrative	4,751	5,013	9,275	9,562
Total Operating Expenses	95,350	65,507	190,980	130,642
Net Operating Income	81,433	86,641	161,619	175,908
Other Income (Expense)
Interest expense	(30,370)	(25,824)	(60,948)	(50,717)
Foreign exchange and other income (expense)	2,270	1,089	3,718	3,620
Total other expense	(28,100)	(24,735)	(57,230)	(47,097)
Income Before Income Taxes	53,333	61,906	104,389	128,811
Provision for income taxes	(12,037)	(14,255)	(25,460)	(16,935)
Net Income	41,296	47,651	78,929	111,876
Foreign currency translation gain / (loss)	(1,525)	14,432	(7,226)	18,316
Comprehensive Income	$ 39,771	$ 62,083	$ 71,703	$ 130,192
Earnings per share
Basic (in dollars per share)	$ 0.67	$ 18.61	$ 1.28	$ 86.88
Diluted (in dollars per share)	$ 0.67	$ 16.76	$ 1.28	$ 78.26
Weighted average common shares outstanding
Basic (in shares)	55,515	2,561	55,552	1,288
Diluted (in shares)	55,519	2,843	55,554	1,430

Combined and Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net income	$ 78,929	$ 111,876
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:
Depreciation and amortization	1,716	2,854
Amortization of debt issuance costs	3,337	2,494
Provision for credit losses	1,380	1,101
Change in Recoveries	(16,067)	0
Stock-based compensation	16,857	0
Deferred income tax	21,893	12,386
Changes in assets and liabilities:
Other assets	2,032	(2,812)
Accounts receivable	(4,745)	(3,175)
Accounts payable and accrued expenses	(22,438)	5,841
Net cash provided by operating activities	82,894	130,565
Cash flows from investing activities
Purchases of property and equipment, net	(531)	(539)
Net cash used in investing activities	(5,978)	(66,938)
Cash flow from financing activities
Proceeds from notes payable	412,452	681,790
Payments on notes payable	(417,798)	(694,872)
Payment of debt issuance costs	(935)	(7,605)
Repurchase of common stock	(58,912)	0
Dividends paid to stockholders	(29,592)	(32,422)
Proceeds from issuance of common stock	0	10,000
Net used in financing activities	(94,785)	(43,109)
Exchange rate effects on cash balances held in foreign currencies	(3,635)	(3,261)
Net decrease in cash and cash equivalents and restricted cash	(21,504)	17,257
Cash and cash equivalents and restricted cash, beginning of period	47,551	38,243
Cash and cash equivalents and restricted cash, end of period	26,047	55,500
Supplemental cash flow disclosures
Interest paid	57,611	43,450
Income taxes paid	4,272	4,748
New leases assumed	45	321
Deferred tax liability recognized in connection with reorganization	0	79,484
Investments in receivables, net
Cash flows from investing activities
Purchases of receivables, net	(301,947)	(300,501)
Collections applied to receivables	296,889	233,761
Credit card receivables
Cash flows from investing activities
Purchases of receivables, net	(11,890)	(13,138)
Collections applied to receivables	$ 11,501	$ 13,479

Combined and Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Assets
Cash and cash equivalents	$ 20,406	$ 23,231
Restricted cash	5,641	24,320
Accounts receivable	16,901	12,245
Other assets	14,281	16,273
Property, plant and equipment, net	1,711	1,695
Other intangible assets, net	5,246	6,541
Goodwill	57,761	58,014
Total Assets	2,083,808	2,087,373
Liabilities
Accounts payable and accrued expenses	73,285	95,208
Other liabilities	3,777	4,179
Current tax liabilities	1,074	855
Deferred tax liabilities	123,688	101,957
Notes payable, net	1,405,794	1,409,039
Total Liabilities	1,607,618	1,611,238
Stockholders' Equity
Common Stock par value $0.0001 per share; 330,000,000 shares authorized as of June 30, 2026 and December 31, 2025 and 57,435,586 and 58,298,923 shares issued and outstanding as of June 30, 2026 and December 31, 2025	6	6
Additional paid-in capital	(32,692)	(49,549)
Retained earnings	513,057	522,632
Accumulated other comprehensive income (loss)	(4,181)	3,046
Total stockholders' equity	476,190	476,135
Total Liabilities and Stockholders' Equity	2,083,808	2,087,373
Investments in receivables, net
Assets
Receivables, net	1,946,819	1,928,742
Credit card receivables
Assets
Receivables, net	$ 15,042	$ 16,312